Non-24-Hour Sleep–Wake Rhythm Disorder in the Totally Blind: Diagnosis and Management

The Use of Exogenous Melatonin in Delayed Sleep Phase Disorder: A Meta-analysis

(2017) Ingeborg M. van Geijlswijk et al.   SLEEP

A Pre-Screening Questionnaire to Predict Non-24-Hour Sleep-Wake Rhythm Disorder (N24HSWD) among the Blind

(2016) Erin E. Flynn-Evans et al.   Journal of Clinical Sleep Medicine

Safety profile of tasimelteon, a melatonin MT1and MT2receptor agonist: pooled safety analyses from six clinical studies

(2015) Damien Leger et al.   Expert Opinion On Drug Safety

Tasimelteon for non-24-hour sleep–wake disorder in totally blind people (SET and RESET): two multicentre, randomised, double-masked, placebo-controlled phase 3 trials

(2015) Steven W Lockley et al.   LANCET

Circadian Rhythm Disorders and Melatonin Production in 127 Blind Women with and without Light Perception

(2014) Erin E. Flynn-Evans et al.   JOURNAL OF BIOLOGICAL RHYTHMS

Global estimates of visual impairment: 2010

(2011) Donatella Pascolini et al.   BRITISH JOURNAL OF OPHTHALMOLOGY

Multiple hypothalamic cell populations encoding distinct visual information

(2011) Timothy M. Brown et al.   JOURNAL OF PHYSIOLOGY-LONDON

Circadian-Related Sleep Disorders and Sleep Medication Use in the New Zealand Blind Population: An Observational Prevalence Survey

(2011) Guy R. Warman et al.   PLoS One

Rod photoreceptors drive circadian photoentrainment across a wide range of light intensities

(2010) Cara M Altimus et al.   NATURE NEUROSCIENCE

Distinct Contributions of Rod, Cone, and Melanopsin Photoreceptors to Encoding Irradiance

(2010) Gurprit S. Lall et al.   NEURON

International Union of Basic and Clinical Pharmacology. LXXV. Nomenclature, Classification, and Pharmacology of G Protein-Coupled Melatonin Receptors

(2010) M. L. Dubocovich et al.   PHARMACOLOGICAL REVIEWS

Alertness, mood and performance rhythm disturbances associated with circadian sleep disorders in the blind

(2008) STEVEN W. LOCKLEY et al.   JOURNAL OF SLEEP RESEARCH

Melatonin agonist tasimelteon (VEC-162) for transient insomnia after sleep-time shift: two randomised controlled multicentre trials

(2008) Shantha MW Rajaratnam et al.   LANCET